文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

细胞来源纳米颗粒是脓毒症的内源性调节因子并具有治疗潜力

Cell-Derived Nanoparticles are Endogenous Modulators of Sepsis With Therapeutic Potential.
PubMed 文献 · Shock · 2017-01-01
一句话结论小鼠盲肠结扎穿刺模型中,应激成纤维细胞来源的细胞外纳米颗粒可降低腹腔IL-6、减少约2个对数级细菌负荷并直接杀菌。

研究采用小鼠盲肠结扎穿刺(CLP)脓毒症模型,观察细胞来源纳米颗粒(CDNPs)在腹腔的聚集及其对宿主反应的影响。CLP后4小时腹腔即出现CDNP聚集,并持续至24小时。将营养剥夺应激的小鼠成纤维细胞系来源CDNPs注射给脓毒症小鼠后,24小时腹腔白细胞介素6水平降低、细菌负荷较对照降低约2个对数级;体外与铜绿假单胞菌(原文写作Pseudomona aeroginosa)共孵育时菌落形成单位减少20%。CFSE标记显示CDNPs优先被F4/80巨噬细胞摄取,摄取细胞CD11b和MHCII表达升高。作者认为CDNPs通过直接杀菌和增强吞噬细胞活化促进感染部位免疫应答与细菌清除,是具有治疗潜力的新型内源性脓毒症调节因子。

要点

  • CLP后4小时腹腔即出现CDNP聚集,24小时仍持续存在。
  • CDNP处理小鼠CLP后24小时腹腔IL-6降低,细菌负荷较对照降低约2个对数级。
  • CDNPs与铜绿假单胞菌共孵育时菌落形成单位减少20%,提示具有杀菌作用。
  • CDNPs优先被F4/80巨噬细胞摄取,摄取细胞CD11b和MHCII表达较对照升高。
  • 作者认为CDNPs通过直接杀菌和增强吞噬细胞活化促进细菌清除,是具有治疗潜力的内源性脓毒症调节因子。

适用人群与场景

  • 小鼠盲肠结扎穿刺(CLP)脓毒症模型。

研究设计与关键结果

  • 研究类型为小鼠CLP脓毒症模型的动物实验;CDNPs从营养剥夺应激的小鼠成纤维细胞系分离后注射给脓毒症小鼠。
  • CLP后4小时腹腔出现早期CDNP聚集,24小时仍有CDNP存在。
  • CDNP处理小鼠CLP后24小时腹腔白细胞介素6水平降低,细菌负荷较对照小鼠降低约2个对数级。
  • CDNPs与铜绿假单胞菌(原文写作Pseudomona aeroginosa)共孵育时菌落形成单位减少20%。
  • CFSE标记CDNPs在CLP时注射,优先被F4/80巨噬细胞摄取,较少与炎性单核细胞和中性粒细胞相关;摄取CDNPs的细胞CD11b和MHCII表达较对照细胞升高。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠CLP脓毒症模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Cell-derived nanoparticles (CDNPs) containing cytosolic proteins and RNAs/DNAs can be isolated from stressed eukaryotic cells. Previously, CDNPs isolated from cultured cells exerted immunomodulatory activities in different infections. Here, we sought to elucidate the role of CDNPs using a murine model of cecal ligation and puncture (CLP). We hypothesized that CDNPs influence the immune response at the site of infection, where severe cellular stress occurs. We observed early CDNP accumulation in the peritoneum after 4 h and continued CDNP presence 24 h after CLP. To determine whether CDNPs influence the host response to sepsis, we isolated CDNPs from a murine fibroblast cell line stressed by nutrient-deprivation, and injected them into septic mice. CDNP-treated mice demonstrated decreased peritoneal interleukin 6 levels and an approximately 2-log lower bacterial load compared with control mice 24 h after CLP. Additionally, a 20% CFU reduction was observed when incubating CDNPs with Pseudomona aeroginosa, indicating that CDNPs are bactericidal. To identify CDNP-responsive cells, CFSE-labeled CDNPs were injected into mice at the time of CLP. We observed that CDNPs were preferentially ingested by F4/80 macrophages, and to a lesser degree, associated with inflammatory monocytes and neutrophils. Strikingly, CDNP-ingesting cells demonstrated elevated CD11b and MHCII expression compared with control cells. Altogether, our data indicate that CDNPs enhance the immune response at the site of infection and promote bacterial clearance, by direct bacterial killing and increasing phagocyte activation. Thus, CDNPs represent a novel, unexplored endogenous sepsis modulator with therapeutic potential.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Kunz N, Xia BT, Kalies KU, et al. Cell-Derived Nanoparticles are Endogenous Modulators of Sepsis With Therapeutic Potential. Shock. 2017. PMID: 28230708. doi:10.1097/SHK.0000000000000855

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。